Shuying Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shuying Peng has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Daming Zuo
Institute of Molecular Immunology, Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, Guangdong Province Key Laboratory of Immune Regulation and Immunotherapy, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China
1 shared publication Hong Wang
1 shared publicationJia Zhou
Guangdong Province Key Laboratory of Proteomics, Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong 510515, China
1 shared publication- Ledong Sun
Department of Dermatology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, China
1 shared publication - Lu Yu
Institute of Molecular Immunology, Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, Guangdong Province Key Laboratory of Immune Regulation and Immunotherapy, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong 510515, China; Department of Blood Transfusion, Henan Provincial People's Hospital, Zhengzhou, Henan 450003, China
1 shared publication Mingxin Jiang
Institute of Molecular Immunology, Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, Guangdong Province Key Laboratory of Immune Regulation and Immunotherapy, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong 510515, China
1 shared publication
Latest Publications
- 8 January 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 147, 113975
Canthaxanthin ameliorates atopic dermatitis in mice by suppressing Th2 immune response
- 8 January 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 147, 113975
Canthaxanthin ameliorates atopic dermatitis in mice by suppressing Th2 immune response